Brii Biosciences Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2020
Period Ending	Sep '25 Sep 11, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2020
Market Capitalization	1,497	717	1,663	5,359	23,698	-	Upgrade
Market Cap Growth	64.88%	-56.90%	-68.97%	-77.38%	-	-	Upgrade
Enterprise Value	-825	-1,880	-1,335	1,551	29,354	-	Upgrade
Last Close Price	2.08	0.98	2.28	7.37	32.90	-	Upgrade
PS Ratio	47.47	13.49	27.01	38.77	208.62	-	Upgrade
PB Ratio	0.56	0.26	0.49	1.50	5.83	-	Upgrade
P/TBV Ratio	0.63	0.27	0.53	1.56	5.79	-	Upgrade
EV/Sales Ratio	-	-	-	11.22	258.41	-	Upgrade
Debt / Equity Ratio	0.00	0.01	0.00	0.00	0.01	-1.39	Upgrade
Asset Turnover	0.01	0.02	0.02	0.04	0.04	0.07	Upgrade
Quick Ratio	42.68	29.97	21.70	13.33	12.13	1.88	Upgrade
Current Ratio	42.98	31.18	22.11	13.43	12.16	1.90	Upgrade
Return on Equity (ROE)	-14.42%	-18.05%	-5.92%	-15.14%	-534.39%	-	Upgrade
Return on Assets (ROA)	-8.42%	-8.55%	-10.33%	-9.17%	-15.64%	-48.59%	Upgrade
Return on Capital (ROIC)	-8.60%	-8.84%	-10.90%	-9.88%	-18.98%	-68.10%	Upgrade
Earnings Yield	-27.51%	-75.46%	-11.58%	-10.22%	-21.57%	-	Upgrade
FCF Yield	-	-55.85%	-39.35%	-10.47%	-4.56%	-	Upgrade
Buyback Yield / Dilution	-0.14%	-0.29%	-0.64%	-64.78%	-129.57%	-7.08%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.